BRITTANY DOXEY: Open Payments
NPI 1003479445 · PORTAGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 83 payments from 18 companies in 2025. Trend: 2023 $772 · 2024 $1,704 · 2025 $1,815
Food & beverage: $1,815
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $243 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $182 |
| Genentech USA, Inc. | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 8 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $136 |
| CSL Behring | 5 | $127 |
| Regeneron Healthcare Solutions, Inc. | 5 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| GENZYME CORPORATION | 3 | $99 |
| PFIZER INC. | 4 | $98 |
Products named: DUPIXENT, Xolair, NEFFY, NUCALA, ORLADEYO, EBGLYSS, TRELEGY ELLIPTA, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across MI — which companies pay providers there.
